13th Tumour Models London Summit 2024, December 4-5, 2024

Conference

genOway presentation

Event
-
December 4, 2024

genOway's presentation on Wednesday, December 4, 2024 | 1:30 p.m. GMT:

Presence of myeloid and lymphoid cells are key for translational tumor biology, efficacy and safety assessment in humanized mouse models

  • Outlining BRGSF-HIS mice: a CD34+-reconstituted model with functional human lymphoid and myeloid compartments without side effects
  • Investigating human immune cell recruitment into tumor microenvironment
  • Studying myeloid cell functionality and their contribution to translatable safety assessment of therapies

13th Tumour Models London Summit 2024, December 4-5, 2024

Get in touch about

Let us know how we can help

Other news & events

13th Tumour Models London Summit 2024, December 4-5, 2024
Conference
genOway presentation
Event
-
Dec 2024
Read on
ESMO (European Society For Medical Oncology) 2024, Barcelona, Spain, September 13-17, 2024
Conference
genOway presentation
Event
-
Sep 2024
Read on
genOway Shanghai at the Chinese Biopharmaceutical Association meeting 2024
Conference
Event
-
Jul 2024
Read on
5th Annual STING & TLR-Targeted Therapies Summit, San Diego, CA, June 19-20, 2024
Conference
genOway presentation
Event
-
Jun 2024
Read on
6th Annual Cell Engager Summit, Boston, MA, May 21-23, 2024
Conference
genOway presentation
Event
-
May 2024
Read on